Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Antiviral Res. 2012 Feb 15;94(1):1–8. doi: 10.1016/j.antiviral.2012.02.001

Fig. 2.

Fig. 2

End-point titration of purified cMAbs. Symbols: 2C9-cIgG (●); 2C9-cIgM (◆); cIgG 1GD5 (alphavirus cross-reactive) (■); cIgM 1MD11 (alphavirus cross-reactive) (▲). IgM cMAbs were titrated in MAC-ELISA and the absorbance was measured at 450nm; IgG cMAbs were titrated in indirect ELISA and absorbance was measured at 405nm and titration results were superimposed. Insert: YFV neutralization end-point titres of MAbs m2C9, 2C9-cIgG, 2C9-cIgM, and cIgG 1GD5, expressed as PRNT50 reciprocal end-points.